Unlocking the potential of
genomic medicine


Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.  More>>

There are no items to display.

Stock Quote

Recent News

More >>
Date Title and Summary
Toggle Summary12/04/2017
PHILADELPHIA , Dec. 4, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today the appointment of Matthew D. Bayley , MD, MBA to its Board of Directors. "We are excited to welcome Matt to our Board of Directors during this important time for the Company," said
Toggle Summary11/02/2017
PHILADELPHIA , Nov. 2, 2017 /PRNewswire/ --  Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the quarter ended September 30, 2017 and provided a corporate update. Third Quarter and Recent Corporate Highlights Initiated screening and
Toggle Summary10/17/2017
PHILADELPHIA , Oct. 17, 2017 /PRNewswire/ --  Aevi Genomic Medicine, Inc. (NASDAQ: GNMX)(the " Company ") today announced the completion of a previously announced private placement of 22.2 million shares of its common stock with warrants to purchase approximately 4.0 million additional shares of

Upcoming Events

More >>
There are currently no events to display.

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Aevi Genomic Medicine, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Copyright Nasdaq. Minimum 15 minutes delayed.